Price gouging, unreasonable arbitrary increases in prices of hygiene products and certain medications, panic-buying on account of Coronavirus (COVID-19) concerns.
Pursuant to Sections 17(g), (s), 18(1)(c), 18(3)(c), 108(1), 115(3), 124(1), 125 and 126 Federal Competition & Consumer Protection Act (FCCPA) The Federal Competition & Consumer Protection Commission continues to monitor and support the national and statewide responses to containing and preventing the spread of COVID-19 and associated developments. The Commission understands the natural apprehension consumers […]
